Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Noble

Showing results (421-430 of 434) with videos related to

Pageof 44
Sort By:
Thorax|March 13, 2016
Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: analysis of data from three phase 3 trials in patients with idiopathic pulmonary fibrosisSteven D Nathan, Carlo Albera, Williamson Z Bradford, et al.
JCI Insight|May 4, 2021
Antibody-mediated depletion of CCR10+EphA3+ cells ameliorates fibrosis in IPFMiriam S Hohmann, David M Habiel, Milena S Espindola, et al.
Thorax|October 16, 2019
Risk factors for disease progression in idiopathic pulmonary fibrosisGanesh Raghu, Brett Ley, Kevin K Brown, et al.
Science Translational Medicine|September 27, 2019
Interleukin-11 is a therapeutic target in idiopathic pulmonary fibrosisBenjamin Ng, Jinrui Dong, Giuseppe D'Agostino, et al.
The New England Journal of Medicine|May 20, 2014
Efficacy and safety of nintedanib in idiopathic pulmonary fibrosisLuca Richeldi, Roland M du Bois, Ganesh Raghu, et al.
The Lancet. Respiratory Medicine|December 13, 2016
Efficacy of simtuzumab versus placebo in patients with idiopathic pulmonary fibrosis: a randomised, double-blind, controlled, phase 2 trialGanesh Raghu, Kevin K Brown, Harold R Collard, et al.
The Journal of Clinical Investigation|February 13, 2025
Metastatic tumor growth in steatotic liver is promoted by HAS2-mediated fibrotic tumor microenvironmentYoon Mee Yang, Jieun Kim, Zhijun Wang, et al.
JAMA|October 7, 2011
Referral to an extracorporeal membrane oxygenation center and mortality among patients with severe 2009 influenza A(H1N1)Moronke A Noah, Giles J Peek, Simon J Finney, et al.
Proceedings of the American Thoracic Society|June 10, 2011
Cell plasticity in lung injury and repair: report from an NHLBI workshop, April 19-20, 2010Zea Borok, Jeffrey A Whitsett, Peter B Bitterman, et al.
Biorxiv : the Preprint Server for Biology|March 27, 2026
Syndecan-1 Promotes Alveolar Type 2 Epithelial Cell Senescence during Lung FibrosisChangfu Yao, Milena Espinola, Xue Liu, et al.
Pageof 44

Showing results (421-430 of 434) with videos related to

Sort By:
Pageof 44
Thorax|March 13, 2016
Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: analysis of data from three phase 3 trials in patients with idiopathic pulmonary fibrosisSteven D Nathan, Carlo Albera, Williamson Z Bradford, et al.
JCI Insight|May 4, 2021
Antibody-mediated depletion of CCR10+EphA3+ cells ameliorates fibrosis in IPFMiriam S Hohmann, David M Habiel, Milena S Espindola, et al.
Thorax|October 16, 2019
Risk factors for disease progression in idiopathic pulmonary fibrosisGanesh Raghu, Brett Ley, Kevin K Brown, et al.
Science Translational Medicine|September 27, 2019
Interleukin-11 is a therapeutic target in idiopathic pulmonary fibrosisBenjamin Ng, Jinrui Dong, Giuseppe D'Agostino, et al.
The New England Journal of Medicine|May 20, 2014
Efficacy and safety of nintedanib in idiopathic pulmonary fibrosisLuca Richeldi, Roland M du Bois, Ganesh Raghu, et al.
The Lancet. Respiratory Medicine|December 13, 2016
Efficacy of simtuzumab versus placebo in patients with idiopathic pulmonary fibrosis: a randomised, double-blind, controlled, phase 2 trialGanesh Raghu, Kevin K Brown, Harold R Collard, et al.
The Journal of Clinical Investigation|February 13, 2025
Metastatic tumor growth in steatotic liver is promoted by HAS2-mediated fibrotic tumor microenvironmentYoon Mee Yang, Jieun Kim, Zhijun Wang, et al.
JAMA|October 7, 2011
Referral to an extracorporeal membrane oxygenation center and mortality among patients with severe 2009 influenza A(H1N1)Moronke A Noah, Giles J Peek, Simon J Finney, et al.
Proceedings of the American Thoracic Society|June 10, 2011
Cell plasticity in lung injury and repair: report from an NHLBI workshop, April 19-20, 2010Zea Borok, Jeffrey A Whitsett, Peter B Bitterman, et al.
Biorxiv : the Preprint Server for Biology|March 27, 2026
Syndecan-1 Promotes Alveolar Type 2 Epithelial Cell Senescence during Lung FibrosisChangfu Yao, Milena Espinola, Xue Liu, et al.
Pageof 44